Abstract
An epidemiological research has been conducted in Province of Novara by examining all cases from 1 January 1966 to 31 December 1975. Alter and Kurtzke's diagnostic criteria have been adopted, possible cases of M.S. were excluded from this study. The mean incidence rate is 1.8/100, the prevalence rate is 19.51/100,000. A higher prevalence rate was observed in the mountains (25.08/100,000). The most important clinical features are discussed with particular reference to the duration of the illness.
| Original language | English |
|---|---|
| Pages (from-to) | 133-141 |
| Number of pages | 9 |
| Journal | Acta Neurologica |
| Volume | 34 |
| Issue number | 2 |
| Publication status | Published - 1979 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
Epidemiological study of multiple sclerosis in the province of Novara. / Caputo, D.; Marforio, S.; Zibetti, A.
In: Acta Neurologica, Vol. 34, No. 2, 1979, p. 133-141.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Epidemiological study of multiple sclerosis in the province of Novara
AU - Caputo, D.
AU - Marforio, S.
AU - Zibetti, A.
PY - 1979
Y1 - 1979
N2 - An epidemiological research has been conducted in Province of Novara by examining all cases from 1 January 1966 to 31 December 1975. Alter and Kurtzke's diagnostic criteria have been adopted, possible cases of M.S. were excluded from this study. The mean incidence rate is 1.8/100, the prevalence rate is 19.51/100,000. A higher prevalence rate was observed in the mountains (25.08/100,000). The most important clinical features are discussed with particular reference to the duration of the illness.
AB - An epidemiological research has been conducted in Province of Novara by examining all cases from 1 January 1966 to 31 December 1975. Alter and Kurtzke's diagnostic criteria have been adopted, possible cases of M.S. were excluded from this study. The mean incidence rate is 1.8/100, the prevalence rate is 19.51/100,000. A higher prevalence rate was observed in the mountains (25.08/100,000). The most important clinical features are discussed with particular reference to the duration of the illness.
UR - http://www.scopus.com/inward/record.url?scp=0018777955&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018777955&partnerID=8YFLogxK
M3 - Article
C2 - 474223
AN - SCOPUS:0018777955
VL - 34
SP - 133
EP - 141
JO - Acta Neurologica
JF - Acta Neurologica
SN - 0001-6276
IS - 2
ER -